VALUE ADDED MEDICINES ONLINE SUMMIT Empowering the healthcare community by improving existing treatments

Position Paper. Incentives Review The Orphan and Paediatric Incentives

Electronic product information: from principles to actions. AESGP, EFPIA and Medicines for Europe reflections on EMAHMA – EC Key principles for electronic product information

Filling the gap: How off-patent medicines can improve the equity and quality of cancer care

Filling the gap: How off-patent medicines can improve the equity and quality of cancer care

White Paper: Anatomy of a failure to launch: A review of barriers to generic and biosimilar market entry and the use of competition law as a remedy

Second wave pandemic preparedness: procurement principles

Policy Roadmap for Medicines Manufacturing Leadership

Call for tenders SANTE/2020/C3/29 for the supply of medicinal products used for intensive care patients subject to the novel coronavirus (COVID-19) disease – policy and technical concerns

COVID-19 “Round 2” – Findings & way forward (Kearney)